Latest responsible investment thinking

  • Supply chains, painkillers and gene editing: ESG risks in pharma

    29 Jun 2022

    Reflecting on ESG risks in the pharmaceutical industry, Sora Utzinger discusses supply chains and counterfeit medicines, access to painkillers, and the ethics of gene editing.

  • What does the data say? Biodiversity loss: From horror to hope

    24 Jun 2022

    In this month’s instalment of our visual series on topical themes, we explore the world of biodiversity.

  • ESG investing: Lasting lessons from Russia’s war on Ukraine

    23 Jun 2022

    Russia’s invasion of Ukraine has led to ESG receiving widespread flak. While much of the criticism is unjustified, the episode underlines how many issues related to ESG are complex and involve trade-offs. Investment approaches may need fine tuning, especially if the geopolitical landscape continues to change so rapidly.

  • Levelling up for a new social contract

    21 Jun 2022

    The global financial crisis of 2007 and the COVID-19 pandemic widened social inequalities, with vulnerable communities hit the hardest. Governments, investors and companies all have a duty to address the issue.

  • Antimicrobial resistance: Q&A with Dame Sally Davies

    10 Jun 2022

    Resistance to antibiotics is already killing millions. Professor Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance, spoke to AIQ on the latest developments to counter antimicrobial resistance Antimicrobial Resistance (AMR) in the UK and globally.

  • Deep water: Ten threats to marine ecosystems

    8 Jun 2022

    Our air, weather, food, the health of diverse marine life and millions of jobs all depend on the ocean. But we have not done well as custodians of marine ecosystems. Here, we set out ten ways where human actions threaten the health of an essential environment.

  • The investment case for nature

    17 May 2022

    The impact of economic activity on the natural world has long been ignored. However, governments, companies and investors can all play a role in helping to protect nature.

  • Levelling up: Investing towards a new social contract

    17 May 2022

    As we learn to live with COVID-19, focus is returning to delivering a just transition. This is important to secure long-term investment outcomes, but also presents direct opportunities.

  • Life force: Why nature matters

    12 May 2022

    Growing awareness that natural systems are stressed or even close to breakdown is prompting asset managers to look closely at nature-based risks and investee companies to understand their environmental impacts and dependencies.

  • Why investors must act now on the biodiversity crisis

    26 Apr 2022

    The concepts of biodiversity and ‘natural capital’ have been largely ignored by business and finance until recently. Investors are now starting to take the issue seriously and build it into their thinking.

  • The challenge of delivering net zero

    11 Apr 2022

    Financial services businesses have begun the complex businesses of working out how to deliver on their net-zero ambitions and play their part in tackling climate change.

  • Facing up to the ESG backlash

    6 Apr 2022

    Asset managers must better explain how ESG can improve investment returns and make the world a better place. Clear guidance to help investors choose between funds is also required.

Subscribe to AIQ

Receive our award-winning insight on key investment themes, direct to your inbox.

AIQ Investment Thinking

Get our perspective on key themes influencing investment markets globally.
Read more

House View

A quarterly publication which encapsulates the thinking of our investment team.

Read more

Important information

This site is intended for U.S. Institutional Investors only. If you are not a U.S. Institutional Investor, please visit the global Aviva Investors homepage.

The content on this site and any posts on Aviva’s other social media or third party platforms is provided for informational and educational purposes (“Online Content”) only, and nothing herein constitutes investment, legal, accounting or tax advice. The Online Content is general in nature, not directed to any category of investors and should not be regarded as individualized, a recommendation, investment advice or a suggestion to engage in or refrain from any investment-related course of action. Investment decisions and the appropriateness of this material should be made based on an investor's individual objectives and circumstances and in consultation with their advisors. Views expressed in “posts” (including podcasts, videos, blogs and social media) by Aviva’s personnel are not necessarily the views of Aviva or its respective affiliates.

Information, examples and any charts shown in the Online Content are for information purposes only current as of the date of this material and is subject to change without notice. Information is obtained from third party sources deemed reliable, but there is no representation or warranty as to its accuracy, completeness or reliability. In addition, posts may include third-party advertisements; Aviva has not reviewed such advertisements and does not endorse any advertising content contained therein.

This material shown in the Online Content may include estimates, outlooks, projections and other “forward-looking statements.” Past performance does not predict future returns. There can be no assurances that the investment objectives will be achieved or investment strategies will be successful. Investments in fixed income entails risk. Due to a variety of factors, actual events or market behavior may differ significantly from any views expressed. Indexes are unmanaged and are not available for direct investment. Past performance is no guarantee of future results.

Aviva Investors Americas LLC is an investment adviser registered with the U.S. Securities and Exchange Commission. Registration as an investment adviser does not imply any special skill or training. Aviva products and services may not be available in all jurisdictions or to all client types.

Except as otherwise authorized, this information may not be shown, copied, transmitted, or otherwise given to any third party without Aviva's prior written consent.